Acurion
Co-Founder and Board Member Magda Marquet, Ph.D., is involved with Acurion. The company's mission is to expand access to precision oncology by improving biomarker detection and treatment selection across multiple advanced cancer types. Acurion develops AI-powered image analysis tools for biomarker detection, uncovering clinically actionable insights from conventional pathology images. Its OncoGaze™ platform applies advanced machine learning to routinely collected pathology slides to identify clinically actionable biomarkers, aiming to accelerate access to precision oncology insights without re
Funding
Every round, secondary, debt facility or acquisition involving Acurion that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see every AI company on Lounge with revenue, funding, valuation and investors, searchable and sortable, plus CSV exports. Plans start at $37/mo.
See plans →Log in